Related references
Note: Only part of the references are listed.Triple-Negative Breast Carcinoma Current and Emerging Concepts
Robert Schmadeka et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
R. Dienstmann et al.
ANNALS OF ONCOLOGY (2014)
Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets
Hee Jin Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
Brian D. Lehmann et al.
JOURNAL OF PATHOLOGY (2014)
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast
Elinor Sawyer et al.
PLOS GENETICS (2014)
Correlation of Clinicopathologic Parameters and Immunohistochemical Features of Triple-negative Invasive Lobular Carcinoma
Aparna Harbhajanka et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
FGFR2 Promotes Breast Tumorigenicity through Maintenance of Breast Tumor-Initiating Cells
Sungeun Kim et al.
PLOS ONE (2013)
The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?
Carole Massabeau et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
Eleonora Brunello et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Multidimensional Identification of Tissue Biomarkers of Gastric Cancer
Tiannan Guo et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Increased Expression of Fibroblastic Growth Factor Receptor 2 Is Correlated With Poor Prognosis in Patients With Breast Cancer
Shanshan Sun et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer
Vikram K. Jain et al.
BREAST CANCER RESEARCH (2012)
FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
Rachel Sharpe et al.
CLINICAL CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers
Aye Aye Thike et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
Aye Aye Thike et al.
MODERN PATHOLOGY (2010)
Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
Ellen Margrethe Haugsten et al.
MOLECULAR CANCER RESEARCH (2010)
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N. Turner et al.
ONCOGENE (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
Somaia Elbauomy Elsheikh et al.
BREAST CANCER RESEARCH (2007)
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Jorge Sergio Reis-Filho et al.
CLINICAL CANCER RESEARCH (2006)
Comprehensive profiling of 8p11-12 amplification in breast cancer
W Gelsi-Boyer et al.
MOLECULAR CANCER RESEARCH (2005)
Share Paper
